HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin Hutchings Selected Research

Martin Hutchings Research Topics

Disease

26Hodgkin Disease (Hodgkin's Disease)
01/2022 - 10/2004
14Lymphoma (Lymphomas)
01/2021 - 04/2008
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2021 - 04/2009
3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2022 - 03/2018
3Cardiotoxicity
10/2020 - 03/2018
3Neoplasms (Cancer)
01/2020 - 09/2012
2Residual Neoplasm
01/2022 - 08/2007
2Febrile Neutropenia
01/2022 - 11/2021
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2021 - 05/2015
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021 - 05/2009
1Second Primary Neoplasms (Neoplasms, Second)
01/2022
1Diarrhea
11/2021
1Hyperbilirubinemia
11/2021
1Infertility (Sterility)
11/2021
1Fever (Fevers)
01/2021
1Ototoxicity
01/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1Disease Progression
03/2018
1Cardiomyopathies (Cardiomyopathy)
03/2018
1Heart Failure
03/2018
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2018
1Hematologic Neoplasms (Hematological Malignancy)
12/2005

Drug/Important Bio-Agent (IBA)

10Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 08/2007
8Dacarbazine (DIC)FDA LinkGeneric
01/2022 - 08/2007
8Vinblastine (Vinblastine Sulfate)FDA Link
01/2022 - 08/2007
7Bleomycin (Blenoxane)FDA LinkGeneric
01/2022 - 08/2007
7Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2021 - 04/2009
6Brentuximab VedotinIBA
01/2022 - 01/2019
4Rituximab (Mabthera)FDA Link
11/2021 - 05/2015
4Deoxyglucose (2 Deoxy D glucose)IBA
06/2012 - 01/2006
3Cytarabine (Cytosar-U)FDA LinkGeneric
01/2021 - 01/2019
2Biological ProductsIBA
01/2022 - 12/2005
2Proteins (Proteins, Gene)FDA Link
11/2021 - 12/2020
2Cisplatin (Platino)FDA LinkGeneric
01/2021 - 01/2019
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 01/2019
1Immunoconjugates (Immunoconjugate)IBA
01/2022
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2022
1Complement C4 (Complement Component 4)IBA
01/2022
1ProteomeIBA
01/2022
1RO6870810IBA
11/2021
1Toll-Like Receptors (Toll-Like Receptor)IBA
11/2021
1venetoclaxIBA
11/2021
1CytokinesIBA
01/2021
1EnzymesIBA
01/2021
1glofitamabIBA
01/2021
1Rubidium-82IBA
10/2020
1Adenosine (Adenocard)FDA LinkGeneric
10/2020
1FluorineIBA
09/2020
1Lenalidomide (CC 5013)FDA Link
03/2018
1AnthracyclinesIBA
03/2018
1Antineoplastic Agents (Antineoplastics)IBA
03/2018
1ibrutinibIBA
03/2018
13-Iodobenzylguanidine (Iobenguane)IBA
03/2018
1AFM13IBA
06/2015
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
05/2015

Therapy/Procedure

13Therapeutics
01/2022 - 10/2004
11Drug Therapy (Chemotherapy)
11/2021 - 01/2006
4Radiotherapy
04/2017 - 03/2007
2Salvage Therapy
01/2021 - 01/2019
1Transplantation
01/2022
1Stem Cell Transplantation
01/2020
1Operative Surgical Procedures
07/2016
1Immunotherapy
06/2015
1Neoadjuvant Therapy
09/2012